Reduction in Mps1 levels or activity in these tumors can lead to loss of cell viability; therefore, inhibition of Mps1 has been regard as an attractive strategy to target cancers, especially those with chromosomal instability (Daniel et al., 2011; Xie et al., 2017). Here, TTK is linked to cancer.